{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:25:39Z","timestamp":1790101539342,"version":"4.0.1"},"reference-count":31,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008717","name":"Sylvia and Charles Viertel Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008717","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Health Research Advisory Committee, Western Australia"},{"DOI":"10.13039\/501100001069","name":"Women and Infants Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2018,6,27]]},"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate if nebulised surfactant reduces intubation requirement in preterm infants with respiratory distress treated with nasal continuous positive airway pressure (nCPAP).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Double blind, parallel, stratified, randomised control trial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Sole tertiary neonatal unit in West Australia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>Preterm infants (29<jats:sup>0<\/jats:sup>\u201333<jats:sup>6<\/jats:sup>\u2009weeks\u2019 gestational age, GA) less than 4\u2009hours of age requiring 22%\u201330%\u2009supplemental oxygen, with informed parental written consent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>Infants were randomised within strata (29<jats:sup>0<\/jats:sup>\u201331<jats:sup>6<\/jats:sup> and 32<jats:sup>0<\/jats:sup>\u201333<jats:sup>6<\/jats:sup>\u2009weeks\u2019 GA) to bubble nCPAP or bubble nCPAP and nebulised surfactant (200\u2009mg\/kg: poractant alfa) using a customised vibrating membrane nebuliser (eFlow neonatal). Surfactant nebulisation (100\u2009mg\/kg) was repeated after 12\u2009hours for persistent supplemental oxygen requirement.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>The primary outcomes were requirement for intubation and duration of mechanical ventilation at 72\u2009hours. Data analysis followed the intention-to-treat principle.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>360 of 606 assessed infants were eligible; 64 of 360 infants were enrolled and randomised (n=32\/group). Surfactant nebulisation reduced the requirement for intubation within 72\u2009hours: 11 of 32 infants were intubated after continuous positive airway pressure (CPAP) and nebulised surfactant compared with 22 of 32 infants receiving CPAP alone (relative risk (95%\u2009CI)=0.526 (0.292 to 0.950)). The reduced requirement for intubation was limited to the 32<jats:sup>0<\/jats:sup>\u201333<jats:sup>6<\/jats:sup>\u2009weeks\u2019 GA stratum. The median (range) duration of ventilation in the first 72\u2009hours was not different between the intervention (0 (0\u201362) hours) and control (9 (0\u201364) hours; p=0.220) groups. There were no major adverse events.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Early postnatal nebulised surfactant may reduce the need for intubation in the first 3\u2009days of life compared with nCPAP alone in infants born at 29<jats:sup>0<\/jats:sup>\u201333<jats:sup>6<\/jats:sup>\u2009weeks\u2019 GA with mild respiratory distress syndrome. Confirmation requires further adequately powered studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ACTRN12610000857000.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/archdischild-2018-315051","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T12:15:43Z","timestamp":1532607343000},"page":"F313-F319","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":106,"title":["Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial"],"prefix":"10.1136","volume":"104","author":[{"given":"Stefan","family":"Minocchieri","sequence":"first","affiliation":[{"name":"Centre for Neonatal Research and Education, School of Medicine, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Neonatal Clinical Care Unit, Women and Newborn Health Service, Perth, Western Australia, Australia"},{"name":"Neonatologie, Kantonsspital Winterthur, Winterthur, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare A","family":"Berry","sequence":"additional","affiliation":[{"name":"Centre for Neonatal Research and Education, School of Medicine, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Jane","family":"Pillow","sequence":"additional","affiliation":[{"name":"Centre for Neonatal Research and Education, School of Medicine, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Neonatal Clinical Care Unit, Women and Newborn Health Service, Perth, Western Australia, Australia"},{"name":"School of Human Sciences, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"2025090509590639000_104.3.F313.1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.6.e560"},{"key":"2025090509590639000_104.3.F313.2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2010.192518"},{"key":"2025090509590639000_104.3.F313.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60986-0"},{"key":"2025090509590639000_104.3.F313.4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211381"},{"key":"2025090509590639000_104.3.F313.5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00005382-199423000-00009","article-title":"Iatrogenic tracheobronchial perforation in infants","volume":"9","author":"Newman","year":"1994","journal-title":"J Thorac Imaging"},{"key":"2025090509590639000_104.3.F313.6","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198406000-00006"},{"key":"2025090509590639000_104.3.F313.7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s001340050459","article-title":"Surfactant nebulisation prevents the adverse effects of surfactant therapy on blood pressure and cerebral blood flow in rabbits with severe respiratory failure","volume":"23","author":"Dijk","year":"1997","journal-title":"Intensive Care Med"},{"key":"2025090509590639000_104.3.F313.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199410203311603"},{"key":"2025090509590639000_104.3.F313.9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000337354","article-title":"Innovation in surfactant therapy II: surfactant administration by aerosolization","volume":"101","author":"Pillow","year":"2012","journal-title":"Neonatology"},{"key":"2025090509590639000_104.3.F313.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2013.08.023"},{"key":"2025090509590639000_104.3.F313.11","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.1.9812017"},{"key":"2025090509590639000_104.3.F313.12","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1097\/00003246-200007000-00058","article-title":"Endotracheal surfactant atomization: an alternative to bolus instillation?","volume":"28","author":"Wagner","year":"2000","journal-title":"Crit Care Med"},{"key":"2025090509590639000_104.3.F313.13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1152\/jappl.1991.70.2.869","article-title":"Aerosolized surfactant treatment of preterm lambs","volume":"70","author":"Lewis","year":"1991","journal-title":"J Appl Physiol"},{"key":"2025090509590639000_104.3.F313.14","first-page":"55","article-title":"Microaerosol administration of synthetic beta-gamma-dipalmitoyl-l-alpha-lecithin in the respiratory distress syndome: a preliminary report","volume":"90","author":"Robillard","year":"1964","journal-title":"Can Med Assoc J"},{"key":"2025090509590639000_104.3.F313.15","first-page":"346","article-title":"Inhalation of aerosolized surfactant (Exosurf) to neonates treated with nasal continuous positive ariway pressure","volume":"1998","author":"Arroe","year":"1998","journal-title":"Prenat Neonat Med"},{"key":"2025090509590639000_104.3.F313.16","doi-asserted-by":"publisher","DOI":"10.1080\/080352500750028195"},{"key":"2025090509590639000_104.3.F313.17","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199709)24:3<222::AID-PPUL9>3.0.CO;2-O"},{"key":"2025090509590639000_104.3.F313.18","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2009.0758"},{"key":"2025090509590639000_104.3.F313.19","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91880-J"},{"key":"2025090509590639000_104.3.F313.20","first-page":"CD008310","article-title":"Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome","volume":"10","author":"Abdel-Latif","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090509590639000_104.3.F313.21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/jamp.2012.0993","article-title":"Vibrating membrane devices deliver aerosols more efficient than standard devices: a study in a neonatal upper airway model","volume":"26","author":"Tiemersma","year":"2013","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"2025090509590639000_104.3.F313.22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000369955","article-title":"Lung deposition of nebulized surfactant in newborn piglets","volume":"107","author":"Linner","year":"2015","journal-title":"Neonatology"},{"key":"2025090509590639000_104.3.F313.23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0301-4622(99)00144-1","article-title":"Ultrasonic surfactant nebulization with different exciting frequencies","volume":"84","author":"Wagner","year":"2000","journal-title":"Biophys Chem"},{"key":"2025090509590639000_104.3.F313.24","doi-asserted-by":"publisher","DOI":"10.1159\/000083370"},{"key":"2025090509590639000_104.3.F313.25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/jp.2015.177","article-title":"Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery","volume":"36","author":"Pinheiro","year":"2016","journal-title":"J Perinatol"},{"key":"2025090509590639000_104.3.F313.26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpeds.2017.09.068","article-title":"Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial","volume":"193","author":"Roberts","year":"2018","journal-title":"J Pediatr"},{"key":"2025090509590639000_104.3.F313.27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000450691","article-title":"Feasibility of laryngeal mask airway device placement in neonates","volume":"111","author":"Wanous","year":"2017","journal-title":"Neonatology"},{"key":"2025090509590639000_104.3.F313.28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/S0103-507X2012000200018","article-title":"ProSealTM laryngeal mask airway for surfactant administration in the treatment of respiratory distress syndrome in a premature infant","volume":"24","author":"Barbosa","year":"2012","journal-title":"Rev Bras Ter Intensiva"},{"key":"2025090509590639000_104.3.F313.29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jped.2016.08.007","article-title":"A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates","volume":"93","author":"Barbosa","year":"2017","journal-title":"J Pediatr"},{"key":"2025090509590639000_104.3.F313.30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1203\/PDR.0b013e318175dcfa","article-title":"Development of the premature infant nose throat-model (PrINT-Model): an upper airway replica of a premature neonate for the study of aerosol delivery","volume":"64","author":"Minocchieri","year":"2008","journal-title":"Pediatr Res"},{"key":"2025090509590639000_104.3.F313.31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-13-59"}],"updated-by":[{"DOI":"10.1136\/archdischild-2018-315051corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000}}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2018-315051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:00:56Z","timestamp":1757091656000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2018-315051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,4,29]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1136\/archdischild-2018-315051"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2018-315051","relation":{"correction":[{"id-type":"doi","id":"10.1136\/archdischild-2018-315051corr1","asserted-by":"object"}]},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]}}}